Online Database of Chemicals from Around the World
| Simagchem Corporation | China | Inquire | ||
|---|---|---|---|---|
 |
+86 13806087780 | |||
 |
sale@simagchem.com | |||
| Chemical manufacturer since 2002 | ||||
| chemBlink standard supplier since 2008 | ||||
| Hangzhou Leap Chem Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
|
+86 (571) 8771-1850 | |||
|
market19@leapchem.com | |||
 |
QQ chat | |||
| Chemical manufacturer since 2006 | ||||
| chemBlink standard supplier since 2015 | ||||
| Amadis Chemical Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
|
+86 (571) 8992-5085 | |||
|
sales@amadischem.com | |||
| Chemical manufacturer since 2010 | ||||
| chemBlink standard supplier since 2015 | ||||
| Carbosynth China Ltd. | China | Inquire | ||
|---|---|---|---|---|
|
+86 (512) 6260-5585 | |||
|
sales@carbosynth.com | |||
|
QQ chat | |||
| Chemical manufacturer since 2006 | ||||
| chemBlink standard supplier since 2016 | ||||
| Dalton Pharma Services | Canada | Inquire | ||
|---|---|---|---|---|
|
+1 (416) 661-2102 | |||
|
chemist@dalton.com | |||
| Chemical manufacturer | ||||
| Santa Cruz Biotechnology, Inc. | USA | Inquire | ||
|---|---|---|---|---|
|
+1 (831) 457-3800 | |||
|
scbt@scbt.com | |||
| Chemical manufacturer | ||||
| Classification | API >> Circulatory system medication |
|---|---|
| Name | Olmesartan |
| Synonyms | 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid |
| Molecular Structure | ![CAS # 144689-24-7, Olmesartan, 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid](/structures/144689-24-7.gif) |
| Molecular Formula | C24H26N6O3 |
| Molecular Weight | 446.50 |
| CAS Registry Number | 144689-24-7 |
| EC Number | 646-413-5 |
| Density | 1.33 |
|---|---|
| Hazard Classification | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for Olmesartan |
